Kod HS/CN 30021091 jest poza zakresem na potrzeby przygotowania EUDR.
Haemoglobin, blood globulins and serum globulins(2012-2016);Haemoglobin, blood globulins and serum globulins(2002-2011);Haemoglobin, blood globulins and serum globulins(1988-2001) Zaindeksowany silnik zakresu zwraca dla tego kodu wynik Out of scope. No Annex I scope match was found for this indexed CN code.
Dlaczego ta strona referencyjna daje taką odpowiedź.
- Opis kodu
- Haemoglobin, blood globulins and serum globulins(2012-2016);Haemoglobin, blood globulins and serum globulins(2002-2011);Haemoglobin, blood globulins and serum globulins(1988-2001)
- Podstawa w załączniku I
- Brak bezpośredniej pozycji w załączniku I
- Podstawa źródłowa
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Wiersze nadrzędne, podrzędne i sąsiednie.
Widok biblioteki służy do nawigacji referencyjnej. Użyj weryfikatora, gdy chcesz uruchomić inny kod jako działanie.
30produkty farmaceutyczneout3002human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar productsout300210antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processesout30021010antisera(2012-2016);antisera(2002-2011);antisera(1988-2001)out30021095blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of human blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out30021098blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes (excl. antisera, haemoglobin, blood globulins and serum globulins)out30021099blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2012-2012);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(2002-2011);blood fractions and modified immunological products, whether or not obtained by means of biotechnological processes, of animal blood (excl. antisera, haemoglobin, blood globulins and serum globulins)(1988-2001)out
Co to oznacza dla przygotowania.
Ten wiersz nie uruchamia bezpośrednio zbierania dowodów w bieżącym wyniku zakresu.
Regulation (EU) 2023/1115 Annex I — relevant productspobrano 2026-08-06Commission Delegated Regulation (EU) 2026/2102 amending Annex I to Regulation (EU) 2023/1115pobrano 2026-09-24Eurostat Comext Combined Nomenclature codelist (CXT_NC v11.0)pobrano 2026-08-06Eurostat Comext partner country codelist (CXT_FREE_ISO)pobrano 2026-08-06Eurostat Comext DS-045409 — EU trade since 1988 by HS2-4-6 and CN8pobrano 2026-08-06Commission Implementing Regulation (EU) 2025/1093 — country benchmarkingpobrano 2026-08-06Regulation (EU) 2025/2650 amending Regulation (EU) 2023/1115 as regards certain obligations of operators and traderspobrano 2025-12-26Commission Implementing Regulation (EU) 2026/1565 amending Implementing Regulation (EU) 2024/3084 (EUDR information system)pobrano 2026-08-08